1KJ.F 10X GENOMICS DL -00001

Healthcare Health Care Technology Frankfurt Exchange
60.86 EUR
Close of Nov 11, 2026
12.96 91.10
Market cap
EUR 7.39B
P/E
-
P/B
9.89x
ROE
-8.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 1KJ.F undervalued?

Graham number

The Graham number of 10X GENOMICS DL -00001 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

10X GENOMICS DL -00001 fundamental analysis

No fundamental analysis for 10X GENOMICS DL -00001 yet.

10X GENOMICS DL -00001 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About 10X GENOMICS DL -00001

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale sing…

Full company profile